Questions discussed in this category

For a node positive, triple negative patient that underwent neoadjuvant chemotherapy followed by breast conservation with a complete pathologic respon...

Assume normal cardiac function and no obvious co-morbidities. No anthracycline previously due to age alone. The patient’s BRCA status is unknown...

Patient previously received neoadjuvant ddAC-T with residual disease at surgery, followed by adjuvant capecitabine which was completed 2 months prior ...

If so, what would be the regimen that you would consider and what factors would sway you for or against chemotherapy for such patients?

Papers discussed in this category

Eur. J. Cancer, 2017 Aug 04

N. Engl. J. Med.,

Journal of the National Comprehensive Cancer Network : JNCCN, 2017-10

N. Engl. J. Med.,

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018-12-01

N Engl J Med, 2021 Jun 03

Annals of surgical oncology, 2019 Jun 21